{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["2-Anilinoquinoline derivatives", "Anti-cancer activity", "SGK1 inhibitors", "Trifluoromethyl group"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "39117890", "DateRevised": {"Year": "2024", "Month": "08", "Day": "08"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1007/s11030-024-10951-4"], "ArticleDate": [{"Year": "2024", "Month": "08", "Day": "09"}], "Journal": {"ISSN": "1573-501X", "JournalIssue": {"PubDate": {"Year": "2024", "Month": "Aug", "Day": "09"}}, "Title": "Molecular diversity", "ISOAbbreviation": "Mol Divers"}, "ArticleTitle": "Discovery of novel 4-trifluoromethyl-2-anilinoquinoline derivatives as potential anti-cancer agents targeting SGK1.", "Abstract": {"AbstractText": ["Given the critical necessity for the development of more potent anti-cancer drugs, a series of novel compounds incorporating trifluoromethyl groups within the privileged 2-anilinoquinoline scaffold was designed, synthesized, and subjected to biological evaluation through a pharmacophore hybridization strategy. Upon evaluating the in vitro anti-cancer characteristics of the target compounds, it became clear that compound 8b, which contains a (4-(piperazin-1-yl)phenyl)amino substitution at the 2-position of the quinoline skeleton, displayed superior efficacy against four cancer cell lines by inducing apoptosis and cell cycle arrest. Following research conducted in a PC3 xenograft mouse model, it was found that compound 8b exhibited significant anti-cancer efficacy while demonstrating minimal toxicity. Additionally, the analysis of a 217-kinase panel pinpointed SGK1 as a potential target for this compound class with anti-cancer capabilities. This finding was further verified through molecular docking analysis and cellular thermal shift assays. To conclude, our results emphasize that compound 8b can be used as a lead compound for the development of anti-cancer drugs that target SGK1."], "CopyrightInformation": "\u00a9 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province/Guizhou Provincial Engineering Research Center for Natural Drugs, Guiyang, 550014, China."}], "LastName": "Xu", "ForeName": "Guangcan", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province/Guizhou Provincial Engineering Research Center for Natural Drugs, Guiyang, 550014, China."}], "LastName": "Li", "ForeName": "Lanlan", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province/Guizhou Provincial Engineering Research Center for Natural Drugs, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "Guizhou University of Traditional Chinese Medicine, Guiyang, 550025, China."}], "LastName": "Lv", "ForeName": "Mengfan", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province/Guizhou Provincial Engineering Research Center for Natural Drugs, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "Guizhou University of Traditional Chinese Medicine, Guiyang, 550025, China."}], "LastName": "Li", "ForeName": "Cheng", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province/Guizhou Provincial Engineering Research Center for Natural Drugs, Guiyang, 550014, China."}], "LastName": "Yu", "ForeName": "Jia", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province/Guizhou Provincial Engineering Research Center for Natural Drugs, Guiyang, 550014, China."}], "LastName": "Zeng", "ForeName": "Xiaoping", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province/Guizhou Provincial Engineering Research Center for Natural Drugs, Guiyang, 550014, China."}], "LastName": "Meng", "ForeName": "Xueling", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province/Guizhou Provincial Engineering Research Center for Natural Drugs, Guiyang, 550014, China."}], "LastName": "Yu", "ForeName": "Gang", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province/Guizhou Provincial Engineering Research Center for Natural Drugs, Guiyang, 550014, China."}], "LastName": "Liu", "ForeName": "Kun", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province/Guizhou Provincial Engineering Research Center for Natural Drugs, Guiyang, 550014, China."}], "LastName": "Cheng", "ForeName": "Sha", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China. luo_heng@gmc.edu.cn."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province/Guizhou Provincial Engineering Research Center for Natural Drugs, Guiyang, 550014, China. luo_heng@gmc.edu.cn."}], "LastName": "Luo", "ForeName": "Heng", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China. bixue_xu@126.com."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province/Guizhou Provincial Engineering Research Center for Natural Drugs, Guiyang, 550014, China. bixue_xu@126.com."}], "LastName": "Xu", "ForeName": "Bixue", "Initials": "B"}], "GrantList": [{"GrantID": "No. QJJ[2022]184", "Agency": "Department of Education of Guizhou Province", "Country": ""}, {"GrantID": "No. 21NSFCP42", "Agency": "Guizhou Medical University", "Country": ""}, {"GrantID": "QKHJC[2023]YB241", "Agency": "Natural Science Foundation of Guizhou Province", "Country": ""}, {"GrantID": "QKHPTRC-GCC[2022]034-1", "Agency": "Natural Science Foundation of Guizhou Province", "Country": ""}, {"GrantID": "QKHZYD[2022]4015", "Agency": "Natural Science Foundation of Guizhou Province", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Mol Divers", "NlmUniqueID": "9516534", "ISSNLinking": "1381-1991"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Cazzolla Gatti R, Di Paola A, Monaco A et al (2023) The spatial association between environmental pollution and long-term cancer mortality in Italy. Sci Total Environ 855:158439. https://doi.org/10.1016/j.scitotenv.2022.158439", "ArticleIdList": ["10.1016/j.scitotenv.2022.158439", "36113788"]}, {"Citation": "Zeng Y, Ren X, Jin P et al (2023) Development of MPS1 inhibitors: recent advances and perspectives. J Med Chem 66:16484\u201316514. https://doi.org/10.1021/acs.jmedchem.3c00963", "ArticleIdList": ["10.1021/acs.jmedchem.3c00963", "38095579"]}, {"Citation": "Cui Z, Chen S, Wang Y et al (2017) Design, synthesis and evaluation of azaacridine derivatives as dual-target EGFR and Src kinase inhibitors for antitumor treatment. Eur J Med Chem 136:372\u2013381. https://doi.org/10.1016/j.ejmech.2017.05.006", "ArticleIdList": ["10.1016/j.ejmech.2017.05.006", "28525838"]}, {"Citation": "El-Damasy AK, Cho NC, Nam G et al (2016) Discovery of a nanomolar multikinase inhibitor (KST016366): a new benzothiazole derivative with remarkable broad-spectrum antiproliferative activity. ChemMedChem 11:1587\u20131595. https://doi.org/10.1002/cmdc.201600224", "ArticleIdList": ["10.1002/cmdc.201600224", "27405013"]}, {"Citation": "Nemr MTM, Elshewy A, Ibrahim ML et al (2024) Design, synthesis, antineoplastic activity of new pyrazolo[3,4-d]pyrimidine derivatives as dual CDK2/GSK3\u03b2 kinase inhibitors; molecular docking study, and ADME prediction. Bioorg Chem 150:107566. https://doi.org/10.1016/j.bioorg.2024.107566", "ArticleIdList": ["10.1016/j.bioorg.2024.107566", "38896936"]}, {"Citation": "Li J, Gong C, Zhou H et al (2024) Kinase inhibitors and kinase-targeted cancer therapies: Recent advances and future perspectives. Int J Mol Sci 25(10):5489. https://doi.org/10.3390/ijms25105489", "ArticleIdList": ["10.3390/ijms25105489", "38791529", "11122109"]}, {"Citation": "Roskoski R Jr (2015) A historical overview of protein kinases and their targeted small molecule inhibitors. Pharm Res 100:1\u201323. https://doi.org/10.1016/j.phrs.2015.07.010", "ArticleIdList": ["10.1016/j.phrs.2015.07.010"]}, {"Citation": "Ayala-Aguilera CC, Valero T, Lorente-Mac\u00edas \u00c1 et al (2022) Small molecule kinase inhibitor drugs (1995\u20132021): medical indication, pharmacology, and synthesis. J Med Chem 65(2):1047\u20131131. https://doi.org/10.1021/acs.jmedchem.1c00963", "ArticleIdList": ["10.1021/acs.jmedchem.1c00963", "34624192"]}, {"Citation": "Fadaly WAA, Nemr MTM, Kahk NM (2024) Discovery of novel pyrazole based Urea/Thiourea derivatives as multiple targeting VEGFR-2, EGFRWT, EGFRT790M tyrosine kinases and COX-2 Inhibitors, with anti-cancer and anti-inflammatory activities. Bioorg Chem 147:107403. https://doi.org/10.1016/j.bioorg.2024.107403", "ArticleIdList": ["10.1016/j.bioorg.2024.107403", "38691909"]}, {"Citation": "Roskoski R Jr (2024) Properties of FDA-approved small molecule protein kinase inhibitors: a 2024 update. Pharmacol Res 200:107059. https://doi.org/10.1016/j.phrs.2024.107059", "ArticleIdList": ["10.1016/j.phrs.2024.107059", "38216005"]}, {"Citation": "Roskoski R Jr (2024) Cost in the United States of FDA-approved small molecule protein kinase inhibitors used in the treatment of neoplastic and non-neoplastic diseases. Pharmacol Res 199:107036. https://doi.org/10.1016/j.phrs.2023.107036", "ArticleIdList": ["10.1016/j.phrs.2023.107036", "38096958"]}, {"Citation": "Shroff R, Goetzl EJ (2024) Protein kinases-high yield targets for cancer and dementia drug discovery: protein kinase treatment targets. Am J Med S0002\u20139343(24):00392\u201300399. https://doi.org/10.1016/j.amjmed.2024.06.016", "ArticleIdList": ["10.1016/j.amjmed.2024.06.016"]}, {"Citation": "Liang X, Wu P, Yang Q et al (2021) An update of new small-molecule anticancer drugs approved from 2015 to 2020. Eur J Med Chem 220:113473. https://doi.org/10.1016/j.ejmech.2021.113473", "ArticleIdList": ["10.1016/j.ejmech.2021.113473", "33906047"]}, {"Citation": "Abd El-Mawgoud HK, AboulMagd AM, Nemr MTM et al (2024) Design, synthesis and cytotoxic evaluation of new thieno[2,3-d]pyrimidine analogues as VEGFR-2/AKT dual inhibitors, apoptosis and autophagy inducers. Bioorg Chem 150:107622. https://doi.org/10.1016/j.bioorg.2024.107622", "ArticleIdList": ["10.1016/j.bioorg.2024.107622", "38996545"]}, {"Citation": "Nemr MTM, AboulMagd AM (2020) New fused pyrimidine derivatives with anticancer activity: Synthesis, topoisomerase II inhibition, apoptotic inducing activity and molecular modeling study. Bioorg Chem 103:104134. https://doi.org/10.1016/j.bioorg.2020.104134", "ArticleIdList": ["10.1016/j.bioorg.2020.104134", "32750610"]}, {"Citation": "Nemr MTM, AboulMagd AM, Hassan HM et al (2021) Design, synthesis and mechanistic study of new benzenesulfonamide derivatives as anticancer and antimicrobial agents via carbonic anhydrase IX inhibition. RSC Adv 11(42):26241\u201326257. https://doi.org/10.1039/d1ra05277b", "ArticleIdList": ["10.1039/d1ra05277b", "35479426", "9037358"]}, {"Citation": "Vitaku E, Smith DT, Njardarson JT (2014) Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals. J Med Chem 57(24):10257\u201310274. https://doi.org/10.1021/jm501100b", "ArticleIdList": ["10.1021/jm501100b", "25255204"]}, {"Citation": "Peng HK, Lin CK, Yang SY et al (2012) Synthesis and anti-HCV activity evaluation of anilinoquinoline derivatives. Bioorg Med Chem Lett 22(2):1107\u20131110. https://doi.org/10.1016/j.bmcl.2011.11.121", "ArticleIdList": ["10.1016/j.bmcl.2011.11.121", "22204909"]}, {"Citation": "Lidumniece E, Withers-Martinez C, Hackett F et al (2022) Subtilisin-like serine protease 1 (SUB1) as an emerging antimalarial drug target: current achievements in inhibitor discovery. J Med Chem 65(19):12535\u201312545. https://doi.org/10.1021/acs.jmedchem.2c01093", "ArticleIdList": ["10.1021/acs.jmedchem.2c01093", "36137276"]}, {"Citation": "Shanley HT, Taki AC, Nguyen N et al (2024) Structure activity relationship and target prediction for ABX464 analogues in Caenorhabditis elegans. Bioorg Med Chem 98:117540. https://doi.org/10.1016/j.bmc.2023.117540", "ArticleIdList": ["10.1016/j.bmc.2023.117540", "38134663"]}, {"Citation": "Shanley HT, Taki AC, Nguyen N et al (2024) Structure-activity relationship and target investigation of 2-aryl quinolines with nematocidal activity. Int J Parasitol Drugs Drug Resist 24:100522. https://doi.org/10.1016/j.ijpddr.2024.100522", "ArticleIdList": ["10.1016/j.ijpddr.2024.100522", "38295619", "10845918"]}, {"Citation": "El-Damasy AK, Haque MM, Park JW et al (2020) 2-Anilinoquinoline based arylamides as broad spectrum anticancer agents with B-RAF<sup>V600E</sup>/C-RAF kinase inhibitory effects: design, synthesis, in vitro cell-based and oncogenic kinase assessments. Eur J Med Chem 208:112756. https://doi.org/10.1016/j.ejmech.2020.112756", "ArticleIdList": ["10.1016/j.ejmech.2020.112756", "32942186"]}, {"Citation": "Peng HK, Lin IL, Lee CC et al (2014) Synthesis and antitumor activity evaluation of anilinoquinoline derivatives by the effect on the expression of polo-like kinase. Med Chem Res 23:1437\u20131446. https://doi.org/10.1007/s00044-013-0749-3", "ArticleIdList": ["10.1007/s00044-013-0749-3"]}, {"Citation": "El-Damasy AK, Cho NC, Pae AN et al (2016) Novel 5-substituted-2-anilinoquinolines with 3-(morpholino or 4-methylpiperazin-1-yl)propoxy moiety as broad spectrum antiproliferative agents: synthesis, cell based assays and kinase screening. Bioorg Med Chem Lett 26(14):3307\u20133312. https://doi.org/10.1016/j.bmcl.2016.05.047", "ArticleIdList": ["10.1016/j.bmcl.2016.05.047", "27241691"]}, {"Citation": "El-Damasy AK, Seo SH, Cho NC et al (2017) Design and synthesis of new 2-anilinoquinolines bearing N-methylpicolinamide moiety as potential antiproliferative agents. Chem Biol Drug Des 89(1):98\u2013113. https://doi.org/10.1111/cbdd.12836", "ArticleIdList": ["10.1111/cbdd.12836", "27496071"]}, {"Citation": "Manevski N, King L, Pitt WR et al (2019) Metabolism by aldehyde oxidase: drug design and complementary approaches to challenges in drug discovery. J Med Chem 62(24):10955\u201310994. https://doi.org/10.1021/acs.jmedchem.9b00875", "ArticleIdList": ["10.1021/acs.jmedchem.9b00875", "31385704"]}, {"Citation": "Abbasi A, Paragas EM, Joswig-Jones CA et al (2019) Time course of aldehyde oxidase and why it is nonlinear. Drug Metab Dispos 47(5):473\u2013483. https://doi.org/10.1124/dmd.118.085787", "ArticleIdList": ["10.1124/dmd.118.085787", "30787100", "6439458"]}, {"Citation": "Neti SS, Wang B, Iwig DF et al (2023) Enzymatic fluoromethylation enabled by the S-adenosylmethionine analog Te-adenosyl-L-(fluoromethyl)homotellurocysteine. ACS Cent Sci 9(5):905\u2013914. https://doi.org/10.1021/acscentsci.2c01385", "ArticleIdList": ["10.1021/acscentsci.2c01385", "37252363", "10214534"]}, {"Citation": "Zhou Y, Wang J, Gu Z et al (2016) Next generation of fluorine-containing pharmaceuticals, compounds currently in phase II\u2212III clinical trials of major pharmaceutical companies: new structural trends and therapeutic areas. Chem Rev 116(2):422\u2013518. https://doi.org/10.1021/acs.chemrev.5b00392", "ArticleIdList": ["10.1021/acs.chemrev.5b00392", "26756377"]}, {"Citation": "Johnson BM, Shu YZ, Zhuo X et al (2020) Metabolic and pharmaceutical aspects of fluorinated compounds. J Med Chem 63(12):6315\u20136386. https://doi.org/10.1021/acs.jmedchem.9b01877", "ArticleIdList": ["10.1021/acs.jmedchem.9b01877", "32182061"]}, {"Citation": "Yuan F, Ding J, Sun Y et al (2024) Synthesis of trifluoromethylated monoterpenes by an engineered cytochrome P450. Chemistry 30(10):e202302936. https://doi.org/10.1002/chem.202302936", "ArticleIdList": ["10.1002/chem.202302936", "38012074"]}, {"Citation": "Kim HJ, Park JW, Seo S et al (2023) Discovery of new quinolone-based diarylamides as potent B-RAF<sup>V600E</sup>/C-RAF Kkinase inhibitors endowed with promising in vitro anticancer activity. Int J Mol Sci 24(4):3216. https://doi.org/10.3390/ijms24043216", "ArticleIdList": ["10.3390/ijms24043216", "36834628", "9963398"]}, {"Citation": "Webster MK, Goya L, Ge Y et al (1993) Characterization of sgk, a novel member of the serine threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum. Mol Cell Biol 13(4):2031\u20132040. https://doi.org/10.1128/mcb.13.4.2031-2040.1993", "ArticleIdList": ["10.1128/mcb.13.4.2031-2040.1993", "8455596", "359524"]}, {"Citation": "Gong GQ, Wang K, Dai XC et al (2018) Identification, structure modification, and characterization of potential small-molecule SGK3 inhibitors with novel scaffolds. Acta Pharmacol Sin 39(12):1902\u20131912. https://doi.org/10.1038/s41401-018-0087-6", "ArticleIdList": ["10.1038/s41401-018-0087-6", "30038340", "6289383"]}, {"Citation": "Pearce LR, Komander D, Alessi DR (2010) The nuts and bolts of AGC protein kinases. Nat Rev Mol Cell Biol 11(1):9\u201322. https://doi.org/10.1038/nrm2822", "ArticleIdList": ["10.1038/nrm2822", "20027184"]}, {"Citation": "Sang Y, Kong P, Zhang S et al (2021) SGK1 in human cancer: emerging roles and mechanisms. Front Oncol 10:608722. https://doi.org/10.3389/fonc.2020.608722", "ArticleIdList": ["10.3389/fonc.2020.608722", "33542904", "7851074"]}, {"Citation": "Basnet R, Gong GQ, Li C et al (2018) Serum and glucocorticoid inducible protein kinases (SGKs): a potential target for cancer intervention. Acta Pharm Sin B 8(5):767\u2013771. https://doi.org/10.1016/j.apsb.2018.07.001", "ArticleIdList": ["10.1016/j.apsb.2018.07.001", "30245963", "6146383"]}, {"Citation": "Cicenas J, Meskinyte-Kausiliene E, Jukna V et al (2022) SGK1 in cancer: biomarker and drug target. Cancers (Basel) 14(10):2385. https://doi.org/10.3390/cancers14102385", "ArticleIdList": ["10.3390/cancers14102385", "35625991"]}, {"Citation": "Jang H, Park Y, Jang J (2022) Serum and glucocorticoid-regulated kinase 1: structure, biological functions, and its inhibitors. Front Pharmacol 13:1036844. https://doi.org/10.3389/fphar.2022.1036844", "ArticleIdList": ["10.3389/fphar.2022.1036844", "36457711", "9706101"]}, {"Citation": "Kathuria A, Priya N, Chand K et al (2012) Substrate specificity of acetoxy derivatives of coumarins and quinolones towards calreticulin mediated transacetylation: investigations on antiplatelet function. Bioorg Med Chem 20(4):1624\u20131638. https://doi.org/10.1016/j.bmc.2011.11.016", "ArticleIdList": ["10.1016/j.bmc.2011.11.016", "22264757"]}, {"Citation": "Tian Z, Cui S, Dongmei L et al (2015) Design, synthesis and insecticidal activities of dihydropyridine fused neonicotinoids compounds with trifluoromethyl group. Res Chem Intermed 41:7437\u20137447. https://doi.org/10.1007/s11164-014-1835-y", "ArticleIdList": ["10.1007/s11164-014-1835-y"]}, {"Citation": "Li W, Xu F, Shuai W et al (2019) Discovery of novel quinoline-chalcone derivatives as potent anticancer agents with microtubule polymerization inhibitory activity. J Med Chem 62(2):993\u20131013. https://doi.org/10.1021/acs.jmedchem.8b01755", "ArticleIdList": ["10.1021/acs.jmedchem.8b01755", "30525584"]}, {"Citation": "Peng F, Liao M, Qin R et al (2022) Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Sig Transduct Target Ther 7(1):286. https://doi.org/10.1038/s41392-022-01110-y", "ArticleIdList": ["10.1038/s41392-022-01110-y"]}, {"Citation": "Fadaly WAA, Elshaier YAMM, Nemr MTM et al (2023) Design, synthesis, modeling studies and biological evaluation of pyrazole derivatives linked to oxime and nitrate moieties as nitric oxide donor selective COX-2 and aromatase inhibitors with dual anti-inflammatory and anti-neoplastic activities. Bioorg Chem 134:106428. https://doi.org/10.1016/j.bioorg.2023.106428", "ArticleIdList": ["10.1016/j.bioorg.2023.106428"]}, {"Citation": "Fadaly WAA, Nemr MTM, Zidan TH et al (2023) New 1,2,3-triazole/1,2,4-triazole hybrids linked to oxime moiety as nitric oxide donor selective COX-2, aromatase, B-RAFV600E and EGFR inhibitors celecoxib analogs: design, synthesis, anti-inflammatory/anti-proliferative activities, apoptosis and molecular modeling study. J Enzyme Inhib Med Chem 38(1):2290461. https://doi.org/10.1080/14756366.2023.2290461", "ArticleIdList": ["10.1080/14756366.2023.2290461", "38061801", "11003496"]}, {"Citation": "Liu K, Zheng M, Lu R et al (2020) The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review. Cancer Cell Int 20(213):1\u201316. https://doi.org/10.1186/s12935-020-01304-w", "ArticleIdList": ["10.1186/s12935-020-01304-w", "31908598", "6941273"]}, {"Citation": "Fadaly WAA, Zidan TH, Kahk NM et al (2023) New pyrazolyl-thiazolidinone/thiazole derivatives as celecoxib/dasatinib analogues with selective COX-2, HER-2 and EGFR inhibitory effects: design, synthesis, anti-inflammatory/anti-proliferative activities, apoptosis, molecular modelling and ADME studies. J Enzyme Inhib Med Chem 38(1):2281262. https://doi.org/10.1080/14756366.2023.2281262", "ArticleIdList": ["10.1080/14756366.2023.2281262", "38010912", "11003491"]}, {"Citation": "Chen Y, Li W, Yang Y et al (2023) Significant increase of anticancer efficacy in vitro and in vivo of liposome entrapped ruthenium(II) polypyridyl complexes. Eur J Med Chem 257:115541. https://doi.org/10.1016/j.ejmech.2023.115541", "ArticleIdList": ["10.1016/j.ejmech.2023.115541", "37295162"]}, {"Citation": "Li J, Cao X, Chu T et al (2023) The circHMGCS1-miR-205\u20135p-ErBB3 axis mediated the sanggenon C-induced anti-proliferation effects on human prostate cancer. Pharmacol Res 187:106584. https://doi.org/10.1016/j.phrs.2022.106584", "ArticleIdList": ["10.1016/j.phrs.2022.106584", "36462326"]}, {"Citation": "Dubbelman AC, Nijenhuis CM, Jansen RS et al (2016) Metabolite profiling of the multiple tyrosine kinase inhibitor lenvatinib: a cross-species comparison. Invest New Drugs 34(3):300\u2013318. https://doi.org/10.1007/s10637-016-0342-y", "ArticleIdList": ["10.1007/s10637-016-0342-y", "27018262"]}, {"Citation": "Michel BW, Steffens LD, Sigman MS (2011) On the mechanism of the palladium-catalyzed tert-butylhydroperoxide-mediated wacker-type oxidation of alkenes using quinoline-2-oxazoline ligands. J Am Chem Soc 133(21):8317\u20138325. https://doi.org/10.1021/ja2017043", "ArticleIdList": ["10.1021/ja2017043", "21553838", "3113657"]}, {"Citation": "Kondo H, Miyamura S, Matsushita K et al (2020) \u03c3-bond hydroboration of cyclopropanes. J Am Chem Soc 142(25):11306\u201311313. https://doi.org/10.1021/jacs.0c05213", "ArticleIdList": ["10.1021/jacs.0c05213", "32539357"]}, {"Citation": "Zhang YQ, Wen ZH, Wan K et al (2018) A novel synthesized 3\u2019, 5\u2019-diprenylated chalcone mediates the proliferation of human leukemia cells by regulating apoptosis and autophagy pathways. Biomed Pharmacother 106:794\u2013804. https://doi.org/10.1016/j.biopha.2018.06.153", "ArticleIdList": ["10.1016/j.biopha.2018.06.153", "29990873"]}]}], "History": [{"Year": "2024", "Month": "6", "Day": "12"}, {"Year": "2024", "Month": "7", "Day": "25"}, {"Year": "2024", "Month": "8", "Day": "9", "Hour": "0", "Minute": "43"}, {"Year": "2024", "Month": "8", "Day": "9", "Hour": "0", "Minute": "43"}, {"Year": "2024", "Month": "8", "Day": "8", "Hour": "23", "Minute": "29"}], "PublicationStatus": "aheadofprint", "ArticleIdList": ["39117890", "10.1007/s11030-024-10951-4", "10.1007/s11030-024-10951-4"]}}]}